Chugai Pharmaceutical Co Ltd (CUP) Stock Price & News

Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia

About Chugai Pharmaceutical Co Ltd

CEOOsamu Okuda

Employees5,1 миң

Founded1925-ж., 10-мар.

Headquarters-

SectorPharmaceutical industry

Websitechugai-pharm.co.jp

All values in JPY	2025-ж. сен.	2025-ж. дек.	2026-ж. мар.	2026-ж. июн.
Revenue	333,18 млд	346,30 млд	321,75 млд	341,58 млд
Cost of goods sold	100,24 млд	87,56 млд	92,79 млд	104,22 млд
Cost of revenue	100,24 млд	87,56 млд	92,79 млд	104,22 млд
Research and development expenses	48,60 млд	52,41 млд	41,89 млд	47,76 млд
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	27,89 млд	36,92 млд	28,90 млд	29,04 млд
Operating expense	76,45 млд	89,74 млд	70,19 млд	76,51 млд
Total operating expenses	176,69 млд	177,30 млд	162,98 млд	180,73 млд
Operating income	156,48 млд	169,01 млд	158,76 млд	160,86 млд
Other non operating income	-356,00 млн	994,00 млн	1,43 млд	3,04 млд
EBT including unusual items	156,07 млд	169,90 млд	160,20 млд	169,02 млд
EBT excluding unusual items	156,07 млд	169,90 млд	160,20 млд	169,02 млд
Income tax expense	44,86 млд	41,50 млд	44,78 млд	52,69 млд
Effective tax rate	28,74%	24,42%	27,95%	31,17%
Other operating expenses	-38,00 млн	405,00 млн	-596,00 млн	-291,00 млн
Net income	111,21 млд	128,41 млд	115,42 млд	116,33 млд
Net profit margin	33,38%	37,08%	35,87%	34,06%
Earnings per share	-	-	-	-
Interest and investment income	-	-	-	5,13 млд
Interest expense	-58,00 млн	-95,00 млн	-	-
Net interest expenses	-58,00 млн	-95,00 млн	-	5,13 млд
Depreciation and amortization charges	-	-	-	-
EBITDA	156,78 млд	200,44 млд	159,26 млд	161,56 млд
Gain or loss from assets sale	-	4,53 млд	-	-

Finance

Ask anything